Logos Global Management LP Cytokinetics Inc Transaction History

Logos Global Management LP

$756 Million
Q3 2024

A detailed history of Logos Global Management LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Logos Global Management LP holds 400,000 shares of CYTK stock, worth $19.5 Million. This represents 2.79% of its overall portfolio holdings.

Number of Shares

400,000

Holding current value

$19.5 Million

% of portfolio

2.79%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $20.5 Million - $24.1 Million	400,000 New	400,000 $21.1 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $97.2 Million - $165 Million	-1,525,000 Reduced 93.85%	100,000 $7.01 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $10.1 Million - $31.3 Million	375,000 Added 30.0%	1,625,000 $136 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $11.8 Million - $14.6 Million	-400,000 Reduced 24.24%	1,250,000 $36.8 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $13 Million - $16.3 Million	400,000 Added 32.0%	1,650,000 $53.8 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $8.34 Million - $11.4 Million	-250,000 Reduced 16.67%	1,250,000 $44 Million
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $7.15 Million - $10.2 Million	-200,000 Reduced 11.76%	1,500,000 $68.7 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $1.93 Million - $2.73 Million	-50,000 Reduced 2.86%	1,700,000 $82.4 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $4.58 Million - $6.6 Million	135,000 Added 8.36%	1,750,000 $68.8 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $8.62 Million - $13.3 Million	290,000 Added 21.89%	1,615,000 $59.4 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $11.2 Million - $15.1 Million	325,000 Added 32.5%	1,325,000 $60.4 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $7.42 Million - $14.3 Million	-400,000 Reduced 28.57%	1,000,000 $35.7 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $13.9 Million - $18.9 Million	700,000 Added 100.0%	1,400,000 $27.7 Million
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $13 Million - $18 Million	700,000 New	700,000 $16.3 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $11.4 Million - $21.5 Million	-750,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $1.03 Million - $1.45 Million	-50,000 Reduced 6.25%	750,000 $16.2 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $6.77 Million - $15 Million	606,871 Added 314.23%	800,000 $18.9 Million
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $1.69 Million - $3.15 Million	193,129 New	193,129 $2.28 Million

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Account

Logos Global Management LP Cytokinetics Inc Transaction History